Filgotinib for Treating Moderately to Severely Active Ulcerative Colitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. - van Asselt, Antoinette D. I.; Armstrong, Nigel; Kimman, Merel; Peeters, Andrea; McDermott, Kevin; Stirk, Lisa; Ahmadu, Charlotte; Govers, Tim M.; Hoentjen, Frank; Joore, Manuela A.; Grimm, Sabine E. (PharmacoEconomics, 2023)